GL1X · GenesisL1 explorer

Research workbench

Crystal structure analysis of the cyanide ARG409LEU variant katg from haloarcula marismortui

Analyse Crystal structure analysis of the cyanide ARG409LEU variant katg from… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3VLI
Type
protein
Length
1,425 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Catalase-peroxidase 2
EC
1.11.1.21
UniProt
O59651
Ligands
HEM, CYN
Pockets
20 · best druggability 0.83

Structure

x-ray diffraction · 2 distinct chains · 46% helix, 8% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACatalase-peroxidase 2 (EC 1.11.1.21)protein71146% helix, 8% strandO59651
BCatalase-peroxidase 2 (EC 1.11.1.21)protein71446% helix, 7% strandO59651

Ligands and binding sites

  • HEM · Protoporphyrin IX containing Fe · ligand · 2 copies · chains A, B
  • CYN · Cyanide ion · ion · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 13 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111190.830.84119empty
26440.830.8772HEM, CYN
35720.830.8873HEM, CYN
49860.800.8279empty
56490.780.8474empty

Interfaces

1 interface between chains.

  • A–B · 3866 Ų buried · 37 hydrogen bonds · protein-protein

Compared structures

  • 3VLI · Crystal Structure Analysis of the Cyanide Arg409Leu Variant KatG from HALOARCULA… · the same entry in another collection · chain A against A, TM-score 1.00
  • O59651 · AlphaFold monomer V2.0 prediction for catalase-peroxidase 2 (O59651) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.